The Department of Health and Human Services, Department of, National Institutes of Health, National Institutes of Health NIAID has issued a Combined Synopsis/Solicitation notice for the procurement of 10X Xenium Assay Kits. These kits are used for biological product manufacturing, specifically for in vitro diagnostic substances, reagents, test kits, and sets. The procurement includes specific brand name supplies for the Xenium Prime 5K Human Pan Tissue and Pathways Assay Kit, Xenium Prime 5K Add-on Custom 51 to 100 Gene Panel, and shipping and handling. The kits are essential for the Neuroimmunological Disease Section's mission to understand, diagnose, prognosticate, and cure neuroimmunological diseases. The Xenium platform instrument allows for high-resolution, imaging-based in situ spatial profiling technology, providing a single-cell resolution map of gene expression patterns within tissue sections. The place of performance is Bethesda, Maryland, United States. The procurement will be processed under FAR Part 13 Simplified Acquisition Procedures, with a small business set-aside. Interested vendors must submit their quotations through the NIAID electronic Simplified Acquisition Submission System (eSASS) website. The deadline for submission is Monday, July 29, 2024, at 11:00 AM EST.